Get startedLog in
    Picture of Taro Pharmaceutical Industries logo

    TARO — Taro Pharmaceutical Industries News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedMid Cap
    All News

    Brief: Taro Reports Qtrly Diluted Earnings Per Share Of $0.73

    Picture of Taro Pharmaceutical Industries logoTaro Pharmaceutical Industries
    27/05/2022 24:03
    May 26 (Reuters) - Taro Pharmaceutical Industries Ltd
 TARO.N :
    * TARO PROVIDES RESULTS FOR THE YEAR ENDED MARCH 31, 2022
    * Q4 SALES $143.3 MILLION
    * QTRLY DILUTED EARNINGS PER SHARE OF $0.73

Source text for Eikon:  ID:nBwJr5Tta 
Further company coverage:  TARO.N 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Taro Pharmaceutical Industries

    See all news